multiple-myeloma

Documents about multiple-myeloma

• Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System#896235ClinicalTrials.gov
• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases#857081ClinicalTrials.gov
• Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer#881792ClinicalTrials.gov
• T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases#834819ClinicalTrials.gov
• Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies#802018ClinicalTrials.gov
• A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor#803415ClinicalTrials.gov
• UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep#843050ClinicalTrials.gov
• Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer#919039ClinicalTrials.gov
• Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies#802013ClinicalTrials.gov
• HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies#911752ClinicalTrials.gov
• Long-term Follow-up Study of Patients Receiving CAR-T Cells#918878ClinicalTrials.gov
• The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen#829913ClinicalTrials.gov
• A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg#844303ClinicalTrials.gov
• Decitabine in Treating Patients With Melanoma or Other Advanced Cancer#872670ClinicalTrials.gov
• Combination Chemotherapy in Treating Patients With Advanced Cancer#909611ClinicalTrials.gov
• Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer#875017ClinicalTrials.gov
• Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers#885719ClinicalTrials.gov
• Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer#901624ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer#993892ClinicalTrials.gov
• Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies#886273ClinicalTrials.gov
• A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy#827172ClinicalTrials.gov
• Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer#902720ClinicalTrials.gov
• Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer#993360ClinicalTrials.gov
• Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation#806322ClinicalTrials.gov
• 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer#829464ClinicalTrials.gov
• Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant#901822ClinicalTrials.gov
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer#832648ClinicalTrials.gov
• St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer#848468ClinicalTrials.gov
• Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial#982035ClinicalTrials.gov
• Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)#806979ClinicalTrials.gov
• Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer#852772ClinicalTrials.gov
• Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.#916522ClinicalTrials.gov
• Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant#829448ClinicalTrials.gov
• Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies#877911ClinicalTrials.gov
• Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia#871497ClinicalTrials.gov
• Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation#867817ClinicalTrials.gov
• Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases#914299ClinicalTrials.gov
• Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation#831008ClinicalTrials.gov
• G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders#835719ClinicalTrials.gov
• Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer#851052ClinicalTrials.gov
• Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder#850078ClinicalTrials.gov
• Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma#911315ClinicalTrials.gov
• Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer#917902ClinicalTrials.gov
• Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant#876217ClinicalTrials.gov
• Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil#872291ClinicalTrials.gov
• Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer#908606ClinicalTrials.gov
• Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma#978811ClinicalTrials.gov
• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant#802893ClinicalTrials.gov
• Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer#805930ClinicalTrials.gov
• Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment#805034ClinicalTrials.gov